Skip to main content
Top
Published in: Annals of Surgical Oncology 3/2010

01-03-2010 | Melanomas

Feasibility of a Novel Approach to Inguinal Lymphadenectomy: Minimally Invasive Groin Dissection for Melanoma

Authors: Keith A. Delman, MD, David A. Kooby, MD, Kenneth Ogan, MD, Wayland Hsiao, MD, Viraj Master, MD, PhD

Published in: Annals of Surgical Oncology | Issue 3/2010

Login to get access

Abstract

Introduction

Inguinal lymphadenectomy for metastatic melanoma is reported to have a complication rate as high as 50%. Wound dehiscence has been reported to occur in more than half of these patients, and as a result many surgeons routinely use sartorius muscle transposition to protect against the potential for exposed vessels. We report feasibility of minimally invasive inguinal lymphadenectomy intended to minimize wound complications inherent to this procedure.

Methods

Five patients with histologically confirmed inguinal metastases from melanoma underwent minimally invasive inguinal lymphadenectomy. Procedures were performed via three ports: one at the apex of the femoral triangle, a second two fingerbreadths medial to the adductors, and the third two fingerbreadths lateral to the sartorius. No inguinal incision was utilized for the purpose of surgery. A standard melanoma dissection was performed through these ports: contents of the femoral triangle and 5 cm up onto the external oblique aponeurosis were removed. To validate this technique, sentinel node biopsy scars were excised to permit visual confirmation of adequate anatomic dissection.

Results

Five patients underwent minimally invasive inguinal lymphadenectomy for metastatic melanoma. Median operative time was 180 (range, 142–223) min, median hospital stay was 1 day, and two patients developed cutaneous erythema but neither suffered wound dehiscence. Median nodal yield was 10 (range, 4–13). Blood loss was <100 ml for all procedures. Median duration of drain usage was 8 (range 7–19) days.

Conclusions

Minimally invasive inguinal lymphadenectomy is feasible for patients with melanoma as demonstrated by nodal yield and visual inspection. This technique may reduce complication rates and wound dehiscence, and the risk of exposed vessels is minimized by eliminating the inguinal incision. This obviates the need for routine sartorius muscle transposition. A prospective, randomized trial comparing the open versus the videoscopic approach is currently in progress.
Literature
1.
go back to reference de Vries M, Hoekstra H, Hoekstra-Weebers J. Quality of life after axillary or groin sentinel lymph node biopsy, with or without completion lymph node dissection, in patients with cutaneous melanoma. Ann Surg Oncol. 2009;16:2840–7.CrossRefPubMed de Vries M, Hoekstra H, Hoekstra-Weebers J. Quality of life after axillary or groin sentinel lymph node biopsy, with or without completion lymph node dissection, in patients with cutaneous melanoma. Ann Surg Oncol. 2009;16:2840–7.CrossRefPubMed
2.
go back to reference Sabel MS, Griffith KA, Arora A, et al. Inguinal node dissection for melanoma in the era of sentinel lymph node biopsy. Surgery. 2007;141:728–35.CrossRefPubMed Sabel MS, Griffith KA, Arora A, et al. Inguinal node dissection for melanoma in the era of sentinel lymph node biopsy. Surgery. 2007;141:728–35.CrossRefPubMed
3.
go back to reference Shaw JH, Rumball EM. Complications and local recurrence following lymphadenectomy. Br J Surg. 1990;77:760–4.CrossRefPubMed Shaw JH, Rumball EM. Complications and local recurrence following lymphadenectomy. Br J Surg. 1990;77:760–4.CrossRefPubMed
4.
go back to reference Poos HPAM, Kruijff S, Bastiaannet E, van Ginkel RJ, Hoekstra HJ. Therapeutic groin dissection for melanoma: risk factors for short-term morbidity. Eur J Surg Oncol. 2009;35:877–83.PubMed Poos HPAM, Kruijff S, Bastiaannet E, van Ginkel RJ, Hoekstra HJ. Therapeutic groin dissection for melanoma: risk factors for short-term morbidity. Eur J Surg Oncol. 2009;35:877–83.PubMed
5.
go back to reference Hughes TM, Thomas JM. Combined inguinal and pelvic lymph node dissection for stage III melanoma. Br J Surg. 1999;86:1493–8.CrossRefPubMed Hughes TM, Thomas JM. Combined inguinal and pelvic lymph node dissection for stage III melanoma. Br J Surg. 1999;86:1493–8.CrossRefPubMed
6.
go back to reference Mortenson M, Xing Y, Weaver S, et al. Fibrin sealant does not decrease seroma output or time to drain removal following inguino-femoral lymph node dissection in melanoma patients: A randomized controlled trial (NCT00506311). World J Surg Oncol. 2008;6:63.CrossRefPubMed Mortenson M, Xing Y, Weaver S, et al. Fibrin sealant does not decrease seroma output or time to drain removal following inguino-femoral lymph node dissection in melanoma patients: A randomized controlled trial (NCT00506311). World J Surg Oncol. 2008;6:63.CrossRefPubMed
7.
go back to reference Bishoff JT, Basler JW, Teichman JM, Thompson IM. Endoscopic subcutaneous modified inguinal lymph node dissection (ESMIL) for squamous cell carcinoma of the penis 301A. J Urol. 2003;169:78.CrossRef Bishoff JT, Basler JW, Teichman JM, Thompson IM. Endoscopic subcutaneous modified inguinal lymph node dissection (ESMIL) for squamous cell carcinoma of the penis 301A. J Urol. 2003;169:78.CrossRef
8.
go back to reference Sotelo R, Sanchez-Salas R, Carmona O, et al. Endoscopic lymphadenectomy for penile carcinoma. J Endourol. 2007;21:364–7.CrossRefPubMed Sotelo R, Sanchez-Salas R, Carmona O, et al. Endoscopic lymphadenectomy for penile carcinoma. J Endourol. 2007;21:364–7.CrossRefPubMed
9.
go back to reference Master V, Ogan K, Kooby D, Hsiao W, Delman K. Leg endoscopic groin lymphadenectomy (LEG procedure): step-by-step approach to a straightforward technique. Eur Urol. 2009;56(5):821–8.CrossRef Master V, Ogan K, Kooby D, Hsiao W, Delman K. Leg endoscopic groin lymphadenectomy (LEG procedure): step-by-step approach to a straightforward technique. Eur Urol. 2009;56(5):821–8.CrossRef
10.
go back to reference Johnson DE, Ames FC. Groin dissection. Chicago: Year Book Medical Publishers; 1985. Johnson DE, Ames FC. Groin dissection. Chicago: Year Book Medical Publishers; 1985.
11.
go back to reference Morton DL, Mozzillo N, Thompson JF, Kashani-Sabet M, Kelley MC, Gammon G. An international, randomized, double-blind, phase 3 study of the specific active immunotherapy agent, Onamelatucel-L (Canvaxin compared to placebo as a post-surgical adjuvant in AJCC stage IV melanoma. Society of Surgical Oncology 59th Annual Cancer Symposium. San Diego, CA, 2006. Morton DL, Mozzillo N, Thompson JF, Kashani-Sabet M, Kelley MC, Gammon G. An international, randomized, double-blind, phase 3 study of the specific active immunotherapy agent, Onamelatucel-L (Canvaxin compared to placebo as a post-surgical adjuvant in AJCC stage IV melanoma. Society of Surgical Oncology 59th Annual Cancer Symposium. San Diego, CA, 2006.
12.
go back to reference Spiess PE, Hernandez MS, Pettaway CA. Contemporary inguinal lymph node dissection: minimizing complications. World J Urol. 2009;27:205–12.CrossRefPubMed Spiess PE, Hernandez MS, Pettaway CA. Contemporary inguinal lymph node dissection: minimizing complications. World J Urol. 2009;27:205–12.CrossRefPubMed
13.
go back to reference Guggenheim MM, Hug U, Jung FJ, et al. Morbidity and recurrence after completion lymph node dissection following sentinel lymph node biopsy in cutaneous malignant melanoma. Ann Surg. 2008;247:687–93.CrossRefPubMed Guggenheim MM, Hug U, Jung FJ, et al. Morbidity and recurrence after completion lymph node dissection following sentinel lymph node biopsy in cutaneous malignant melanoma. Ann Surg. 2008;247:687–93.CrossRefPubMed
14.
go back to reference Sarnaik AA, Puleo CA, Zager JS, Sondak VK. Limiting the morbidity of inguinal lymphadenectomy for metastatic melanoma. Cancer Control. 2009;16:240–7.PubMed Sarnaik AA, Puleo CA, Zager JS, Sondak VK. Limiting the morbidity of inguinal lymphadenectomy for metastatic melanoma. Cancer Control. 2009;16:240–7.PubMed
15.
go back to reference Bilimoria K, Balch C, Bentrem D, et al. Complete lymph node dissection for sentinel node-positive melanoma: assessment of practice patterns in the United States. Ann Surg Oncol. 2008;15:1566–76.CrossRefPubMed Bilimoria K, Balch C, Bentrem D, et al. Complete lymph node dissection for sentinel node-positive melanoma: assessment of practice patterns in the United States. Ann Surg Oncol. 2008;15:1566–76.CrossRefPubMed
16.
go back to reference A comparison of laparoscopically assisted and open colectomy for colon cancer. N Engl J Med. 2004;350:2050–9. A comparison of laparoscopically assisted and open colectomy for colon cancer. N Engl J Med. 2004;350:2050–9.
Metadata
Title
Feasibility of a Novel Approach to Inguinal Lymphadenectomy: Minimally Invasive Groin Dissection for Melanoma
Authors
Keith A. Delman, MD
David A. Kooby, MD
Kenneth Ogan, MD
Wayland Hsiao, MD
Viraj Master, MD, PhD
Publication date
01-03-2010
Publisher
Springer-Verlag
Published in
Annals of Surgical Oncology / Issue 3/2010
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-009-0816-7

Other articles of this Issue 3/2010

Annals of Surgical Oncology 3/2010 Go to the issue